JPRN-jRCTb040200026招募中未知
Clinical trial on treatment of knee osteoarthritis using spheroid of adipose-derived mesenchymal stem cells
Shuji HAYASHI0 个研究点目标入组 20 人开始时间: 2020年7月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 80age old（—）
- 性别
- All
入选标准
- •1) KL Grade I or higher knee osteoarthritis patients
- •2) Patient who have pain (VAS>4) at the target site more than 3 months before the date of consent
- •3) Men and women whose consent acquisition date is more than 20 years and less than 80 years
- •4) Patients who can appropriately evaluate pain from start of screening to the end of observation for 48 weeks
- •5) Patients who have received sufficient explanation using ICF and understand the contents, and who have obtained written consent to participate in the study group based on their free will
- •6) Patients who can follow the scedule established until the end of the examination period
排除标准
- •1) Patients with pain other than the primary disease corresponding to any of the following within 7 days before the first administration day-Pain other than the target site suring the screening period average 4 or more (Lumbar spinal canal stenosis, etc.)
- •2) Patients who have inflammatory diseases other than synovitis due to the primary disease at the target site on the screening test day or the first administration day, or patients with a history of these diseases within one year before obtaining consent
- •3) Patients who have undergone surgical procedures including arthroscopy for the disease site (exclucding drainage of joint fluid)
- •4) Patients who received physical therapy of the primary disease within 28 days before the screening start date
- •5)Patients with a history or complication of malignancy within 5 years before obtaining consent
- •6) Patients with the following symptoms or diseases that may affect the results
- •-patients with severe heart disease, liver disease, kidney disease, blood disease or immunodeficiency
- •-patients with systemic joint disease such as rheumatoid arthritics and gout
- •-patients with peripheral neuropathy
- •-patients with osteonecrosis of the disease site
- •-patients with mental illness such as depression, dementia, schizophenia and anxiety
- •-patients scheduled for surgery during the period from the date of consent to the end of observation for 12 months
- •7) Patients who have a history or complication of drug dependence or alcoholism
- •8) Patients iudged inappropriate by doctors
研究者
相似试验
招募中
1 期
Clinical trial on osteoarthritis using spheroid of adipose-derived mesenchymal stem cellsKnee osteoarthritisJPRN-jRCTb032220282Hayashi Shuji20
招募中
1 期
Clinical trial on osteoarthritis using chondrocyte spheroids differentiated from adipose-derived mesenchymal stem cellsOsteoarthritisJPRN-jRCTb032220281Hayashi Shuji20
进行中（未招募）
1 期
Trial comparing three commercially available injection therapies for treatment of knee osteoarthritisKnee osteoarthritis (OA). Osteoarthritis (OA) is a debilitating disease which mostly affects people over 60 years of age. It is known to be within the top 10 contributors to years lived with disability worldwide1. The increasing number of patients with symptomatic OA in an ageing population will continue to place an increasingly larger economic burden on global healthcare systems. The knee is a common location for the disease, causing pain, stiffness and problems with sleep and daily activities.EUCTR2021-000180-70-IEBeacon Hospital135
招募中
1 期
Clinical study and treatment of knee osteoarthritis (qi stagnation and blood stasis) by acupuncture of Quchi point combined needle dommunity outreachKnee osteoarthritisITMCTR2000003511Beijing Yanqing District Hospital (Beijing University Third Hospital Yanqing Hospital)
尚未招募
1 期
A clinical study on the treatment of knee osteoarthritis with homologous acupuncture of shape and qiFA01.0knee osteoarthritisITMCTR2024000220Sichuan Hospital of Integrated Chinese and Western Medicine